Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
about
Hormonal therapies in young breast cancer patients: when, what and for how long?Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?New insights into endocrine therapy for young women with breast cancer.Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.
P2860
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
@ast
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
@en
type
label
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
@ast
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
@en
prefLabel
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
@ast
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
@en
P2860
P356
P1476
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
@en
P2093
Rebecca Aft
P2860
P304
P356
10.2147/IJWH.S29101
P407
P577
2012-10-18T00:00:00Z